Sofinnova Venture Partners VII L P

Sofinnova Venture Partners VII L P is a declared insider at 4 companies; the most frequent names are Trius Therapeutics Inc, Amarin CORP Plc\uk and Aerie Pharmaceuticals Inc. Over a trading history stretching from 6 August 2010 to 7 May 2015, the count stands at 19 filings.

Market trades split into 2 purchases (€6.3M) and 10 sales (€47.8M). Taken together, the sales exceed the purchases by €41.5M. Unlike grants, an open-market purchase is paid for by the insider, at the market price.

On 8 May 2015 came the latest disclosure, a transaction for €79.3M in Hyperion Therapeutics Inc. The latest purchase dates back some time: it was published 5,927 days ago, on 18 August 2010. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.